| NDC Code | 0069-0106-01 |
|---|
| Package Description | 1 VIAL, GLASS in 1 CARTON (0069-0106-01) / 5 mL in 1 VIAL, GLASS |
|---|
| Product NDC | 0069-0106 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Elelyso |
|---|
| Non-Proprietary Name | Taliglucerase Alfa |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20120501 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA022458 |
|---|
| Manufacturer | Pfizer Laboratories Div Pfizer Inc |
|---|
| Substance Name | TALIGLUCERASE ALFA |
|---|
| Strength | 200 |
|---|
| Strength Unit | U/5mL |
|---|
| Pharmacy Classes | Glucosylceramidase [CS], Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
|---|